Nephros (NEPH) Tax Provisions (2025 - 2026)
Nephros (NEPH) posted Tax Provisions of $13000.0 for Q2 2026, down 92.57% on a QoQ basis from $175000.0 in Q4 2025, and up 44.44% year-over-year from $9000.0 in Q2 2025.
Powered by 
Analysis
Nephros (NEPH) Tax Provisions (2025 - 2026) Analysis & Trends
Nephros has reported Tax Provisions for 2 years, with the latest figure at $13000.0 in Q2 2026.
- On a quarterly basis, Tax Provisions rose 44.44% year-over-year to $13000.0 in Q2 2026; TTM through Jun 2026 was $200000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $187000.0, up 281.63% from the prior year.
- Tax Provisions was $13000.0 for Q2 2026 at Nephros, down from $175000.0 in the prior quarter.
- The five-year high for Tax Provisions was $175000.0 in Q4 2025, with the low at $3000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 596.00 Mn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 231.40 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 289.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 288.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 155.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 278.40 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 46.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 68.40 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 72.50 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 13,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Dec 31, 2025 | 175,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 9,000.00 |